Samsung Biologics Co Ltd Long-term Investment Intensity
Samsung Biologics Co Ltd long-term investment intensity. Samsung Biologics Co Ltd (207940) has a Long-term Investment Intensity of 43.2% as of December 2018. Long-term investments of ₩2.59 Trillion represent 43.2% of total assets of ₩5.98 Trillion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read 207940 total debt and obligations for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Samsung Biologics Co Ltd (2014–2018)
Long-term investment intensity of Samsung Biologics Co Ltd from 2014 to 2018. This chart shows how Samsung Biologics Co Ltd's Long-term Investment Intensity has evolved across 5 annual periods from 2014 to 2018. As of December 2018, the intensity stands at 43.2%, reflecting long-term investments of ₩2.59 Trillion against total assets of ₩5.98 Trillion KRW.
Samsung Biologics Co Ltd Long-term Investment Intensity by Year (2014–2018)
Samsung Biologics Co Ltd long-term investment intensity by year from 2014 to 2018. The table below presents the year-by-year Long-term Investment Intensity for Samsung Biologics Co Ltd from 2014 to 2018, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 207940 asset base.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 43.2% | ₩2.59 Trillion | ₩5.98 Trillion | ▼ -26.5 pp |
| 2017 | 69.7% | ₩5.01 Trillion | ₩7.18 Trillion | ▲ +4.1 pp |
| 2016 | 65.6% | ₩4.94 Trillion | ₩7.53 Trillion | ▼ -15.5 pp |
| 2015 | 81.2% | ₩4.84 Trillion | ₩5.96 Trillion | ▲ +77.2 pp |
| 2014 | 4.0% | ₩53.92 Billion | ₩1.36 Trillion | — |